LGVN (Longeveron) Beneish M-Score: -1.05 (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LGVN Longeveron Inc LGVN
45 GF Score
Price $0.61
GF Value $0.38
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Longeveron Beneish M-Score?

Longeveron LGVN +1.40% 45 Beneish M-Score is -1.05 as of Jul. 19, 2026. GuruFocus rates LGVN with a GF Score™ of 45/100 and a GF Value™ of $0.38 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 825 Biotechnology companies, Longeveron ranks worse than 77.45% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.05 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Longeveron's Beneish M-Score or its related term are showing as below:

LGVN' s Beneish M-Score Range Over the Past 10 Years
Min: -7.19   Med: -3.08   Max: -0.04
Current: -1.05

During the past 8 years, the highest Beneish M-Score of Longeveron was -0.04. The lowest was -7.19. And the median was -3.08.


Longeveron Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Longeveron's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longeveron Beneish M-Score Chart

Longeveron Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial -7.19 -0.04 -3.81 -1.74 -4.01

Longeveron Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.84 -4.19 -5.34 -4.01 -1.05

LGVN vs MRKR, PLUR, VYNE: Beneish M-Score Comparison

For the Biotechnology subindustry, Longeveron's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Longeveron Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longeveron's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Longeveron's Beneish M-Score falls into.


LGVN
45GF Score
Longeveron Inc LGVN
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Longeveron Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Longeveron for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 4.2904+0.528 * 1.2635+0.404 * 0.8898+0.892 * 0.5465+0.115 * 0.7997
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.9657+4.679 * -0.215134-0.327 * 1.278
=-1.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $0.07 Mil.
Revenue was 0.398 + 0.365 + 0.137 + 0.316 = $1.22 Mil.
Gross Profit was 0.264 + 0.257 + 0.125 + 0.146 = $0.79 Mil.
Total Current Assets was $16.86 Mil.
Total Assets was $21.21 Mil.
Property, Plant and Equipment(Net PPE) was $2.10 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.06 Mil.
Selling, General, & Admin. Expense(SGA) was $11.83 Mil.
Total Current Liabilities was $4.35 Mil.
Long-Term Debt & Capital Lease Obligation was $0.06 Mil.
Net Income was -4.736 + -5.444 + -7.221 + -5.028 = $-22.43 Mil.
Non Operating Income was 0.039 + -0.045 + 0.089 + 0.369 = $0.45 Mil.
Cash Flow from Operations was -4.37 + -5.296 + -5.055 + -3.597 = $-18.32 Mil.
Total Receivables was $0.03 Mil.
Revenue was 0.381 + 0.603 + 0.773 + 0.468 = $2.23 Mil.
Gross Profit was 0.275 + 0.53 + 0.682 + 0.344 = $1.83 Mil.
Total Current Assets was $15.28 Mil.
Total Assets was $20.85 Mil.
Property, Plant and Equipment(Net PPE) was $3.08 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.13 Mil.
Selling, General, & Admin. Expense(SGA) was $11.01 Mil.
Total Current Liabilities was $2.72 Mil.
Long-Term Debt & Capital Lease Obligation was $0.66 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.068 / 1.216) / (0.029 / 2.225)
=0.055921 / 0.013034
=4.2904

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1.831 / 2.225) / (0.792 / 1.216)
=0.822921 / 0.651316
=1.2635

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (16.855 + 2.099) / 21.21) / (1 - (15.275 + 3.081) / 20.848)
=0.106365 / 0.119532
=0.8898

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1.216 / 2.225
=0.5465

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.127 / (1.127 + 3.081)) / (1.057 / (1.057 + 2.099))
=0.267823 / 0.334918
=0.7997

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(11.828 / 1.216) / (11.01 / 2.225)
=9.726974 / 4.948315
=1.9657

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.06 + 4.345) / 21.21) / ((0.664 + 2.724) / 20.848)
=0.207685 / 0.16251
=1.278

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-22.429 - 0.452 - -18.318) / 21.21
=-0.215134

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Longeveron has a M-score of -1.05 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.05 mean?
Longeveron (LGVN) has a Beneish M-Score of -1.05 as of Jul. 19, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Longeveron and its competitors. According to the industry distribution chart, Longeveron ranks #639 out of 825 companies in the Biotechnology industry, placing it in the top 77.5%.
Is Longeveron's Beneish M-Score too high?
Longeveron's current Beneish M-Score is -1.05. Based on the distribution chart, Longeveron ranks #639 out of 825 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Longeveron has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Longeveron's Beneish M-Score compare to MRKR and PLUR?
According to the Biotechnology industry distribution chart, Longeveron ranks #639 out of 825 companies for Beneish M-Score. This places Longeveron in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Longeveron and its competitors. Longeveron's current Beneish M-Score is -1.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longeveron stock overvalued right now?
Based on GuruFocus' analysis, Longeveron (LGVN) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.38, compared to a current price of $0.61 — trading 60.8% above its estimated fair value. The current Beneish M-Score is -1.05. Longeveron's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Longeveron (LGVN), the current Beneish M-Score is -1.05 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Longeveron (LGVN) Overvalued in 2026?

Based on GuruFocus' analysis, Longeveron stock appears to be overvalued. The current stock price of $0.61 is trading 60.8% above its estimated GF Value™ of $0.38. GuruFocus considers Longeveron to be Significantly Overvalued.

Key valuation signals for LGVN:

  • Beneish M-Score: -1.05
  • GF Value™: $0.38 vs. price of $0.61 (60.8% above fair value)
  • GF Score™: 45/100 with 6 warning signs

No single metric tells the full story. See the LGVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Longeveron Business Description

Address 1951 NW 7th Avenue, Suite 520, Miami, FL, USA, 33136
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
45GF Score

Get the complete analysis for LGVN

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.61
Price
$0.38
GF Value